News
Article
Author(s):
Following the President’s claims connecting the drug to an increased risk of autism when used during pregnancy, Tylenol has found itself in an unexpected spotlight.
President Trump claimed that there is a connection between Tylenol and autism.
Stock.adobe.com
On Monday, September 22, President Trump announced that FDA would be altering its recommendations on the usage of acetaminophen during pregnancy. According to him, women shouldn’t take Tylenol when pregnant because of an increased risk of autism. He suggested that pregnant women with fevers should only take the medication if it’s absolutely necessary.
While there is some research that suggests an association between autism and exposure to acetaminophen during pregnancy, there is no evidence of a causal relationship between the two.1 The Trump administration cited a observational study which suggested the association. However, larger and more detailed studies have found no evidence of a connection between Tylenol and autism.
Tylenol is the only over-the-counter pain medication that is considered safe for pregnant women. Other, similar medications (such as Advil or ibuprofen) have been shown to increase the risk of certain dangerous conditions occurring, such as kidney damage to the developing baby. Also, since a high fever can negatively impact a fetus, so pregnant women may take Tylenol to reduce the fever.
Tylenol is owned by Kenvue. The company was previously a part of Johnson & Johnson but became fully independent in 2023. The company also owns several other high-profile brands such as Band-Aid and Listerine.
A class-action lawsuit was previously filed against Kenvue due to claims that exposure to acetaminophen caused babies to develop autism.2 However, the federal case was dismissed due to a lack of scientific evidence (although the plaintiffs have appealed). There is concern that the President’s recent remarks could spark new lawsuits. On the other hand, many have speculated that Kenvue may attempt to file a lawsuit against the Trump Administration if the claims are proven to be untrue. As of yet, no lawsuits have been filed as a result of President Trump’s claims.
There is debate as to whether it is safe to give Tylenol to a newborn. Generally speaking, it is a good idea to consult with a physician before giving medicine to a newborn.
FDA is part of the Trump administration and has made similar claims about the risk of Tylenol usage during pregnancy. However, international regulatory agencies have rejected the claims. Health officials in the UK have no plans to change their recommendations.
The medical and scientific community are still researching the causes of autism. The leading theory, supported by evidence, says that autism is likely a genetic condition that is the result of a combination of genetic and developmental conditions. While some groups have attempted to blame outside sources, such as Tylenol during pregnancy or vaccines, to autism, there is little to no evidence supporting these claims.
Tylenol, made from acetaminophen, is considered to be the only safe over-the-counter painkiller for pregnant women. Other medications, such as Advil and ibuprofen, have been linked to increased risk factors, such as kidney damage.
Following initial rumors that the Trump administration planned to announce a link between autism and Tylenol, parent company Kenvue’s stock began to drop. Following the announcement, the stock dropped to an all-time low. However, the stock briefly rebounded before dropping again.
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.